RA CAPITAL MANAGEMENT, L.P.
Top Portfolio Positions
84 positions ·
$10,185,022,315 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ASND |
Ascendis Pharma A/S
Healthcare
|
10,281,496 | $2,351,686,580 | 23.09% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
24,449,198 | $1,420,742,894 | 13.95% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
6,666,837 | $579,814,813 | 5.69% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
12,198,625 | $467,207,337 | 4.59% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
9,905,045 | $397,093,254 | 3.90% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
10,428,437 | $328,495,765 | 3.23% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
9,550,191 | $305,701,613 | 3.00% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
2,534,145 | $259,623,155 | 2.55% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
2,611,733 | $219,176,633 | 2.15% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
7,692,750 | $208,396,597 | 2.05% |
Portfolio Trend
25 quarters · across all stocks
Holdings in PCVX
Shares Held
Position Value (USD)
23 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $666,788,947 | 11,474,599 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $753,953,947 | 12,974,599 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $494,832,997 | 10,724,599 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $431,014,995 | 11,965,991 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $389,014,367 | 11,965,991 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $460,262,266 | 12,189,149 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $711,297,093 | 8,689,190 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $992,913,741 | 8,689,190 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $619,465,464 | 8,203,754 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $495,570,751 | 7,891,254 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $394,089,224 | 7,891,254 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $273,276,199 | 7,291,254 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $280,865,159 | 5,857,459 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $109,948,872 | 4,581,203 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $99,686,977 | 4,581,203 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $110,636,052 | 4,581,203 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $100,880,638 | 4,240,464 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $98,863,465 | 3,896,865 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $87,019,338 | 3,865,808 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $76,349,708 | 3,865,808 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $98,593,272 | 3,710,699 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $260,914,932 | 5,283,818 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $173,513,011 | 5,489,181 | Shares | Sole | 2020-08-14 | |
| No 13F history on record for this holder in this stock. | ||||||